title: The acute effects of gabapentin in combination with alcohol in heavy drinkers.
abstract: BACKGROUND
  Alcohol effects in humans involve gamma-amino butyric acid (GABA) neurotransmission. It has been proposed that GABAergic medications may be effective in the treatment of alcohol dependence. This study evaluated the acute effects of gabapentin, an anticonvulsant that increases extracellular GABA, on the subjective, physiological, and performance effects of alcohol in heavy (mean 34 drinks per week) alcohol drinkers.
  
  
  METHODS
  Seventeen volunteers without alcohol dependence were tested using a double-blind design with three 3-day long inpatient phases, each separated by at least a 1-week wash-out period. Each phase, gabapentin (0, 1000, or 2000mg) was administered 4h before alcohol (0.75g/kg), which was given in four divided doses every 20min.
  
  
  RESULTS
  Gabapentin impaired the ability to balance without producing changes in subjective, physiological or other performance measures. Pretreatment with gabapentin did not significantly alter subjective and performance effects of alcohol and did not alter alcohol craving. Gabapentin, dose-dependently enhanced alcohol-induced tachycardia.
  
  
  CONCLUSIONS
  Acute gabapentin administration was well tolerated in combination with alcohol, but did not alter the effects of alcohol.
authors.affiliation: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, 1051 Riverside Dr., Unit #120, New York, NY 10032, USA. amb107@columbia.edu
authors.forename: Adam
authors.initials: A
authors.lastname: Bisaga
authors.forename: Suzette M
authors.initials: SM
authors.lastname: Evans
mesh_terms: D000328:Adult; D000435:Alcoholic Intoxication / Q000523:psychology; D000437:Alcoholism / Q000097:blood / Q000523:psychology*; D000588:Amines / Q000493:pharmacokinetics / Q000494:pharmacology*; D000927:Anticonvulsants / Q000493:pharmacokinetics / Q000494:pharmacology*; D003509:Cyclohexanecarboxylic Acids / Q000493:pharmacokinetics / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004347:Drug Interactions; D000431:Ethanol / Q000009:adverse effects* / Q000097:blood; D005260:Female; D018755:GABA Agonists / Q000493:pharmacokinetics / Q000494:pharmacology*; D000077206:Gabapentin; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D011939:Mental Recall / Q000187:drug effects; D009042:Motivation; D009483:Neuropsychological Tests; D004856:Postural Balance / Q000187:drug effects; D011292:Premedication; D011597:Psychomotor Performance / Q000187:drug effects; D014706:Verbal Learning / Q000187:drug effects; D005680:gamma-Aminobutyric Acid / Q000493:pharmacokinetics / Q000494:pharmacology*
chemical_list: D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D018755:GABA Agonists; D000431:Ethanol; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin